Erectile and ejaculatory outcomes after holmium laser enucleation of the prostate: A comprehensive narrative review
Abstract
ABSTRACT Holmium laser enucleation of the prostate (HoLEP) has emerged as a widely adopted surgical technique for the management of benign prostatic hyperplasia (BPH), regardless of prostate size; however, its impact on male sexual function—particularly in terms of erectile and ejaculatory outcomes—remains a subject of ongoing debate. The aim of this study is to critically evaluate the effects of HoLEP on male sexual function (SF), with emphasis on erectile and ejaculatory outcomes, intraoperative considerations, and comparative effectiveness versus other surgical treatments for BPH. The narrative review was conducted using PubMed, Web of Science, and Google Scholar to identify English‐language clinical studies, cohort trials, randomized controlled trials, and meta‐analyses published between January 2000 and May 2025. Included studies evaluated SF before and after HoLEP using validated tools such as the International Index of Erectile Function (IIEF) and the Male Sexual Health Questionnaire‐Ejaculatory Dysfunction (MSHQ‐EjD). The literature indicates that HoLEP has a neutral to modestly favorable effect on erectile function (EF). Transient declines may occur in the early postoperative period, with most patients returning to baseline by three to six months. In contrast, retrograde ejaculation is a frequent and expected outcome, with incidence rates typically ranging from 74% to 78%. While various surgical modifications—such as modified enucleation techniques and partial…
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.